Aims and scope
Aims and scope
Current Microbiology serves as a pivotal platform for scientists to share their discoveries, exchange ideas, and contribute to the progress of microbiological knowledge. The journal prioritizes articles of broad interest, with significant novelty in any of the fields of Microbiology. Current Microbiology publishes significant and original contributions in various domains of basic microbiology research, encompassing original research articles, short communications, reviews, and letters to the editor. The sections include:
- Infectious Disease
- Antimicrobial Resistance
- Host-Microbe Interactions
- Environmental Diversity
- Food Microbiology
- Microbial Biotechnology
- Microbial Physiology & Metabolism
- Systematics
- Genomic Microbiology and Microbial Evolution
- Eukaryotic Microorganisms
- Viruses
Editorial Policies:
Manuscripts submitted to Current Microbiology must adhere to rigorous scientific standards, ensuring originality, clarity, and ethical conduct.
The journal advocates for open science, encouraging data and resource sharing to foster collaboration and transparency in microbiological research.
Topical review articles are welcomed, provided authors demonstrate sufficient expertise in the field. Authors are advised to discuss the content with the Editors before submission, outlining how the manuscript differs from recent review articles in the field.
In its origins, Current Microbiology was a reference journal for microbial taxonomists. Recently the journal has expanded its scope and is considering technically sound science in any sub-discipline of Microbiology. However, it keeps strict for microbe identification. Microbial isolates must be accurately identified and characterized using molecular methods. A mandatory 16S rRNA gene sequence comparison (more than 1000 nt) is required between prokaryotic isolates and validly named type strains of species.
The journal does not consider for publication:
- Studies demonstrating enzyme activities of not-purified enzyme mixtures.
- Studies on using herbal extracts when components are not identified or a reference is not used.
- Systematic reviews and meta-analysis.
- Case reports and clinical trial studies.
- Routine clinical studies from single sites that do not allow to draw epidemiological conclusions.
- Genome sequences without a minimum of analysis, and rigorous phylogeny for proper identification.
- The identification of resistant strains in the clinical setting without justifying a minimum of novelty (i.e. a new resistance determinant, a new genetic structure or trait association).
- Deep sequencing of amplicons or metagenomic studies of different samples that merely follow routine application of different algorithms. We request at least some functional study.